Last updated on December 2019

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04


Brief description of study

A 52-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG) with respect to the core signs and symptoms of diabetic gastroparesis.

Clinical Study Identifier: NCT03383146

Find a site near you

Start Over